Artiva Biotherapeutics (ARTV) Return on Equity (2024 - 2025)
Artiva Biotherapeutics (ARTV) has disclosed Return on Equity for 2 consecutive years, with 0.7% as the latest value for Q4 2025.
- For Q4 2025, Return on Equity fell 38.0% year-over-year to 0.7%; the TTM value through Dec 2025 reached 0.7%, down 38.0%, while the annual FY2025 figure was 0.57%, 474.0% up from the prior year.
- Return on Equity hit 0.7% in Q4 2025 for Artiva Biotherapeutics, down from 0.57% in the prior quarter.
- Across five years, Return on Equity topped out at 0.03% in Q2 2024 and bottomed at 6.59% in Q3 2024.